Bausch Health Companies (BHC) Competitors $4.30 -0.04 (-0.92%) As of 01:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BHC vs. ROIV, LNTH, TGTX, RVMD, BBIO, LEGN, BPMC, SRPT, TLX, and AXSMShould you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Roivant Sciences (ROIV), Lantheus (LNTH), TG Therapeutics (TGTX), Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Legend Biotech (LEGN), Blueprint Medicines (BPMC), Sarepta Therapeutics (SRPT), Telix Pharmaceuticals Limited American Depositary Shares (TLX), and Axsome Therapeutics (AXSM). These companies are all part of the "pharmaceutical products" industry. Bausch Health Companies vs. Roivant Sciences Lantheus TG Therapeutics Revolution Medicines BridgeBio Pharma Legend Biotech Blueprint Medicines Sarepta Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Axsome Therapeutics Roivant Sciences (NASDAQ:ROIV) and Bausch Health Companies (NYSE:BHC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, community ranking, institutional ownership and dividends. Which has more volatility and risk, ROIV or BHC? Roivant Sciences has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Does the MarketBeat Community believe in ROIV or BHC? Bausch Health Companies received 305 more outperform votes than Roivant Sciences when rated by MarketBeat users. However, 78.26% of users gave Roivant Sciences an outperform vote while only 61.16% of users gave Bausch Health Companies an outperform vote. CompanyUnderperformOutperformRoivant SciencesOutperform Votes5478.26% Underperform Votes1521.74% Bausch Health CompaniesOutperform Votes35961.16% Underperform Votes22838.84% Do institutionals and insiders believe in ROIV or BHC? 64.8% of Roivant Sciences shares are owned by institutional investors. Comparatively, 78.7% of Bausch Health Companies shares are owned by institutional investors. 7.9% of Roivant Sciences shares are owned by company insiders. Comparatively, 8.1% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts prefer ROIV or BHC? Roivant Sciences currently has a consensus price target of $17.50, indicating a potential upside of 71.74%. Bausch Health Companies has a consensus price target of $7.17, indicating a potential upside of 65.51%. Given Roivant Sciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe Roivant Sciences is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Bausch Health Companies 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Is ROIV or BHC more profitable? Bausch Health Companies has a net margin of -0.48% compared to Roivant Sciences' net margin of -119.54%. Roivant Sciences' return on equity of -14.05% beat Bausch Health Companies' return on equity.Company Net Margins Return on Equity Return on Assets Roivant Sciences-119.54% -14.05% -12.81% Bausch Health Companies -0.48%-577.82%5.24% Which has stronger earnings and valuation, ROIV or BHC? Roivant Sciences has higher earnings, but lower revenue than Bausch Health Companies. Roivant Sciences is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoivant Sciences$122.59M59.31$4.35B-$0.15-67.93Bausch Health Companies$9.63B0.17-$46M-$0.12-36.08 Does the media favor ROIV or BHC? In the previous week, Bausch Health Companies had 1 more articles in the media than Roivant Sciences. MarketBeat recorded 10 mentions for Bausch Health Companies and 9 mentions for Roivant Sciences. Roivant Sciences' average media sentiment score of 1.26 beat Bausch Health Companies' score of 0.48 indicating that Roivant Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Roivant Sciences 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Bausch Health Companies 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryRoivant Sciences beats Bausch Health Companies on 10 of the 19 factors compared between the two stocks. Remove Ads Get Bausch Health Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHC vs. The Competition Export to ExcelMetricBausch Health CompaniesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$1.59B$6.35B$5.35B$18.51BDividend YieldN/A3.23%5.11%4.25%P/E Ratio-36.086.7721.7431.06Price / Sales0.17228.59376.0426.47Price / Cash0.9465.6738.1517.54Price / Book-4.875.886.444.29Net Income-$46M$141.32M$3.20B$1.02B7 Day Performance-9.90%8.32%6.19%6.63%1 Month Performance-39.40%-12.93%-8.79%-6.86%1 Year Performance-49.86%-12.47%9.69%1.19% Bausch Health Companies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHCBausch Health Companies4.0049 of 5 stars$4.30-0.9%$7.17+66.7%-50.6%$1.58B$9.63B-35.8319,900Short Interest ↑Positive NewsGap DownROIVRoivant Sciences2.6205 of 5 stars$9.26-2.1%$17.50+89.0%-6.9%$6.61B$122.59M-61.73860Positive NewsHigh Trading VolumeLNTHLantheus4.346 of 5 stars$95.45+5.0%$129.43+35.6%+68.0%$6.54B$1.53B15.88700Positive NewsTGTXTG Therapeutics3.3154 of 5 stars$37.25-0.3%$40.67+9.2%+171.3%$5.85B$329.00M-372.46290Positive NewsRVMDRevolution Medicines3.8192 of 5 stars$31.40+0.3%$65.23+107.7%+1.1%$5.84B$742,000.00-8.75250Positive NewsHigh Trading VolumeBBIOBridgeBio Pharma4.5753 of 5 stars$30.67-2.2%$52.64+71.6%+29.9%$5.83B$221.90M-10.76400Analyst ForecastPositive NewsLEGNLegend Biotech2.4082 of 5 stars$30.25-5.5%$79.00+161.2%-39.3%$5.56B$627.24M-31.841,070Positive NewsGap DownBPMCBlueprint Medicines2.6202 of 5 stars$80.20-1.8%$124.95+55.8%-5.4%$5.13B$508.82M-74.26640Positive NewsHigh Trading VolumeSRPTSarepta Therapeutics4.6795 of 5 stars$52.40-3.7%$163.18+211.4%-55.5%$5.08B$1.90B41.92840Short Interest ↑High Trading VolumeTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$14.25+4.7%$22.00+54.4%N/A$4.81B$783.21M0.00N/AAXSMAxsome Therapeutics4.5288 of 5 stars$98.50-0.4%$169.80+72.4%+49.7%$4.80B$385.69M-16.44380Analyst Revision Remove Ads Related Companies and Tools Related Companies Roivant Sciences Alternatives Lantheus Alternatives TG Therapeutics Alternatives Revolution Medicines Alternatives BridgeBio Pharma Alternatives Legend Biotech Alternatives Blueprint Medicines Alternatives Sarepta Therapeutics Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives Axsome Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHC) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
